Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Femara (Sequence 1)
Total 0 results
Nothing found
Sponsors and Collaborators
Korean Society of Spine Surgery
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Hospital Durand, Argentina
GFI
Hospital ASEPEYO Sant Cugat
Eurofins Genoma
Nacuity Pharmaceuticals, Inc.
Neurophth Therapeutics Inc
RMIT University, Melbourne, Australia
iCAD
Mª Victoria Maestre Sanchez
Alma Lasers Inc.
Kupfer, David J., M.D.
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Aptis Medical
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Apollo Neuroscience, Inc.
ASST Cremona, Cremona
Agency for Science, Technology and Research
Everett Meyer
View Full List
Medical Conditions
Hospital Acquired Pressure Ulcer
Renal Function Disorder
Extraarticular Fracture
Accuracy and Precision of Noninvasive Measurement
Post Covid-19 Condition
Surgical Patient
Anatomic Stage 2A Breast Cancer AJCC v8
Anaplastic Large-cell Lymphoma
Decay
Optimys Femoral Stem
STEMI - ST-segment Elevation Myocardial Infarction
LOW OVARIAN RESPONSE
Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use
PD-1 Refractory Advanced Melanoma
Dislocation, Shoulder
Artificial Pancreas
Social Anxiety
Neck Mass
Age-related Hearing Loss
Sporadic
View Full List
Drug Interventions
Oxycodone/acetaminophen 5/325 mg
Letrozole
Midazolam
GLPG1837 multiple ascending doses
Capecitabine/cisplatin
Intravenous deferiprone
OnabotulinumtoxinA
Olopatadine
Desvenlafaxine
MLN2480
PD-1/PD-L1 inhibitor
Standard of care (SOC) for COVID-19
Anticholinergic
Intravenous Formulation of PD-0332991
RDX227675
THC
Camptosar
TPN-101
Fospropofol disodium, propofol
Capecitabine and IMRT (if randomized to this arm)
View Full List
CROs by country
Contract Research Organizations in Canada
Contract Research Organizations in Croatia
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Italy
Contract Research Organizations in Latvia
Contract Research Organizations in Lithuania
Contract Research Organizations in Madagascar
Contract Research Organizations in Mali
Contract Research Organizations in Mauritius
Contract Research Organizations in Rwanda
Contract Research Organizations in South Africa
Contract Research Organizations in Sweden
Contract Research Organizations in Venezuela
CRO list by country
CROs in Togo
SGS
All CROs in Togo
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe